Start-up firm finds salt-free sibutramine

CTC Bio, a Korean venture start-up, said it has acquired a new patent for salt-free sibutramine it claims can demonstrate an equal absorption rate compared with an original anti-obesity agent.

We will carry out more clinical tests in order to improve its efficiency in the battle against obesity,'' CTC Bio President Kim Sung-rin said.

Kim expects the salt-free sibutramine to be commercial...